Ischemia-modified albumin in relation to exercise stress testing
Eftihia Sbarouni1, Panagiota Georgiadou, George N Theodorakis
12nd Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece. elbee@ath.forthnet.gr
Journal of the American College of Cardiology
|December 19, 2006
Summary
Ischemia-modified albumin (IMA) levels fluctuate during exercise stress testing (EST) in coronary artery disease patients. These changes occur regardless of whether the test is positive or negative, suggesting IMA may not specifically indicate myocardial ischemia during EST.
Area of Science:
- Cardiology
- Biomarkers
- Exercise Physiology
Background:
- Ischemia-modified albumin (IMA) is recognized as a marker of myocardial ischemia.
- IMA levels increase following coronary angioplasty and in acute coronary syndromes.
Purpose of the Study:
- To investigate changes in plasma IMA levels during exercise stress testing (EST) in patients with known coronary artery disease (CAD).
- To determine if these IMA level changes differ between positive and negative EST results.
Main Methods:
- Studied 40 consecutive patients diagnosed with established coronary artery disease.
- Collected venous blood samples for IMA measurement at three time points: pre-EST (baseline), peak exercise, and 60 minutes post-EST.
- Analyzed IMA levels in relation to EST outcomes (positive vs. negative).
Main Results:
- IMA levels showed significant differences across the three time points (p = 0.012).
- No significant interaction was observed between IMA changes and EST results (p = 0.94).
- IMA levels decreased at peak exercise and increased post-exercise, returning to baseline in both positive and negative EST groups.
Conclusions:
- Plasma IMA levels significantly change during EST in CAD patients.
- Observed IMA fluctuations during EST did not differ between positive and negative tests.
- These findings suggest that IMA changes during EST may not be a specific indicator of myocardial ischemia.
